05957nam a2200913 a 4500001001400000003000400014008004100018020001800059039006600077041000800143099001000151100002900161245014300190260003100333300001200364505005100376505009300427505008200520505006300602505008400665505006200749505007700811505009400888505007500982505006801057505008301125505008801208505005801296505006901354505007601423505008501499505008301584505009301667505007901760505008101839505007401920505008401994505007702078505008002155505008102235505008302316505008602399505008502485505007902570505004702649505009102696505006302787505008902850505005402939505006602993505005803059505008903117505005003206505005403256505011603310505008503426505005503511505005303566505007503619505005003694505005803744505008603802505005303888505010303941505006504044505007504109505005804184505005604242505005904298505005904357505008004416505036504496650001904861650003504880700003404915856007004949942000705019999001705026vtls000079092MTX160715121                  001 0   eng d  a9780803645813 9a201607151159bstaffc201606141508dstaffy201605041223zadmin0 aeng  aEbook1 aWoo, Teri Moser.911528300aPharmacotherapeutics for advance practice nurse prescribers, forth editionh[electronic resource] /cWoo, Teri Moser;Robinson, Marylou V..  bF.A. Davis Company,c2015.  a1417 p.0 gChapter, Lesson, ParttUnit I: THE FOUNDATION.0 gChapter, Lesson, ParttChapter 1. THE ROLE OF THE ADVANCED PRACTICE NURSE AS PRESCRIBER.0 gChapter, Lesson, ParttChapter 2. REVIEW OF BASIC PRINCIPLES OF PHARMACOLOGY.0 gChapter, Lesson, ParttChapter 3. RATIONAL DRUG SELECTION.0 gChapter, Lesson, ParttChapter 4. LEGAL AND PROFESSIONAL ISSUES IN PRESCRIBING.0 gChapter, Lesson, ParttChapter 5. ADVERSE DRUG REACTIONS.0 gChapter, Lesson, ParttChapter 6. FACTORS THAT FOSTER POSITIVE OUTCOMES.0 gChapter, Lesson, ParttChapter 7. CULTURAL AND ETHNIC INFLUENCES IN PHARMACOTHERAPEUTICS.0 gChapter, Lesson, ParttChapter 8. AN INTRODUCTION TO PHARMACOGENOMICS.0 gChapter, Lesson, ParttChapter 9. NUTRITION AND NUTRACEUTICALS.0 gChapter, Lesson, ParttChapter 10. HERBAL THERAPY AND NUTRITIONAL SUPPLEMENTS.0 gChapter, Lesson, ParttChapter 11. INFORMATION TECHNOLOGY AND PHARMACOTHERAPEUTICS.0 gChapter, Lesson, ParttChapter 12. PHARMACOECONOMICS.0 gChapter, Lesson, ParttChapter 13. OVER-THE-COUNTER MEDICATIONS.0 gChapter, Lesson, ParttUNIT II: PHARMACOTHERAPEUTICS WITH SINGLE DRUGS.0 gChapter, Lesson, ParttChapter 14. DRUGS AFFECTING THE AUTONOMIC NERVOUS SYSTEM.0 gChapter, Lesson, ParttChapter 15. DRUGS AFFECTING THE CENTRAL NERVOUS SYSTEM.0 gChapter, Lesson, ParttChapter 16. DRUGS AFFECTING THE CARDIOVASCULAR AND RENAL SYSTEMS.0 gChapter, Lesson, ParttChapter 17. DRUGS AFFECTING THE RESPIRATORY SYSTEM.0 gChapter, Lesson, ParttChapter 18. DRUGS AFFECTING THE HEMATOPOIETIC SYSTEM.0 gChapter, Lesson, ParttChapter 19. DRUGS AFFECTING THE IMMUNE SYSTEM.0 gChapter, Lesson, ParttChapter 20. DRUGS AFFECTING THE GASTROINTESTINAL SYSTEM.0 gChapter, Lesson, ParttChapter 21. DRUGS AFFECTING THE ENDOCRINE SYSTEM.0 gChapter, Lesson, ParttChapter 22. DRUGS AFFECTING THE REPRODUCTIVE SYSTEM.0 gChapter, Lesson, ParttChapter 23. DRUGS AFFECTING THE INTEGUMENTARY SYSTEM.0 gChapter, Lesson, ParttChapter 24. DRUGS USED IN TREATING INFECTIOUS DISEASES.0 gChapter, Lesson, ParttChapter 25. DRUGS USED IN TREATING INFLAMMATORY PROCESSES.0 gChapter, Lesson, ParttChapter 26. DRUGS USED IN TREATING EYE AND EAR DISORDERS.0 gChapter, Lesson, ParttUNIT III: PHARMACOTHERAPEUTICS WITH MULTIPLE DRUGS.0 gChapter, Lesson, ParttChapter 27. ANEMIA.0 gChapter, Lesson, ParttChapter 28. CHRONIC STABLE ANGINA AND LOW-RISK UNSTABLE ANGINA.0 gChapter, Lesson, ParttChapter 29. ANXIETY AND DEPRESSION.0 gChapter, Lesson, ParttChapter 30. ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE.0 gChapter, Lesson, ParttChapter 31. CONTRACEPTION.0 gChapter, Lesson, ParttChapter 32. DERMATOLOGICAL CONDITIONS.0 gChapter, Lesson, ParttChapter 33. DIABETES MELLITUS.0 gChapter, Lesson, ParttChapter 34. GASTROESOPHAGEAL REFLUX AND PEPTIC ULCER DISEASE.0 gChapter, Lesson, ParttChapter 35. HEADACHES.0 gChapter, Lesson, ParttChapter 36. HEART FAILURE.0 gChapter, Lesson, ParttChapter 37. HUMAN IMMUNODEFICIENCY VIRUS DISEASE AND ACQUIRED IMMUNODEFICIENCY SYNDROME.0 gChapter, Lesson, ParttChapter 38. HORMONE REPLACEMENT THERAPY AND OSTEOPOROSIS.0 gChapter, Lesson, ParttChapter 39. HYPERLIPIDEMIA.0 gChapter, Lesson, ParttChapter 40. HYPERTENSION.0 gChapter, Lesson, ParttChapter 41. HYPERTHYROIDISM AND HYPOTHYROIDISM.0 gChapter, Lesson, ParttChapter 42. PNEUMONIA.0 gChapter, Lesson, ParttChapter 43. SMOKING CESSATION.0 gChapter, Lesson, ParttChapter 44. SEXUALLY TRANSMITTED INFECTIONS AND VAGINITIS.0 gChapter, Lesson, ParttChapter 45. TUBERCULOSIS.0 gChapter, Lesson, ParttChapter 46. UPPER RESPIRATORY INFECTIONS, OTITIS MEDIA, AND OTITIS EXTERNA.0 gChapter, Lesson, ParttChapter 47. URINARY TRACT INFECTIONS.0 gChapter, Lesson, ParttUNIT IV: SPECIAL DRUG TREATMENT CONSIDERATIONS.0 gChapter, Lesson, ParttChapter 48. WOMEN AS PATIENTS.0 gChapter, Lesson, ParttChapter 49. MEN AS PATIENTS.0 gChapter, Lesson, ParttChapter 50. PEDIATRIC PATIENTS.0 gChapter, Lesson, ParttChapter 51. GERIATRIC PATIENTS.0 gChapter, Lesson, ParttChapter 52. PAIN MANAGEMENT: ACUTE AND CHRONIC PAIN.0 aCover, Title,Pharmacotherapeutics for advance practice nurse prescribers, forth edition--Preface, Introduction, TOC,DEDICATION--Preface, Introduction, TOC,PREFACE--Preface, Introduction, TOC,ABOUT THE AUTHORS--Preface, Introduction, TOC,CONTRIBUTORS--Preface, Introduction, TOC,REVIEWERS--Preface, Introduction, TOC,CONTENTS--References, Appendix, Index,Index.  aNursing918303  aPharmacology & Dosages91152841 aRobinson, Marylou V..911528540uhttp://portal.igpublish.com/iglibrary/search/FADAVISB0000493.html  c10  c75656d75656